Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes
- 23 Downloads
The clinical benefits of on-line hemodiafiltration (HDF) versus high-flux membranes hemodialysis (hf-HD) are still debated. In fact, although a superiority of one treatment over the other, especially in terms of mortality, did not emerge from the analysis of clinical trials, improved intradialytic vascular stability and cardiovascular mortality have been observed in patients undergoing HDF rather than hf-HD; the lower removal of sodium (Na+) during HDF seems to play a major role. The plasma concentration of Na+ is the major determinant of plasma tonicity, which, by determining the flow of water between the intracellular and the extracellular compartment, contributes to the vascular refilling process and the maintenance of blood pressure during the hemodialysis treatment. Plasma tonicity also depends on plasma glucose concentration, especially in patients with diabetes mellitus with hyperglycaemia at the start of hemodialysis treatment.
Materials and methods
We evaluated the removal of Na+ and plasma tonicity balance during a 2-week period by performing 2–3 consecutive sessions of hf-HD followed by 2–3 consecutive sessions of HDF, or vice versa, in 47 patients (40% diabetics) on chronic hemodialysis. Identical parameters were used in all dialytic sessions.
Na+ removal per session was − 224 ± 144 mmol and − 219 ± 152 mmol, respectively, in hf-HD and in HDF (p = 0.79). The plasma tonicity balance per session was − 575 ± 310 mOsm and − 563 ± 328 mOsm, respectively, in hf-HD and in HDF (p = 0.75).
The removal of Na+ and plasma tonicity balance did not differ between hf-HD and HDF. This observation suggests that factors other than those assessed in our study might explain the improved cardiovascular stability reported in HDF.
KeywordsSodium removal Plasma tonicity balance Hemodialysis Hemodiafiltration High-flux membranes
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
We have obtained informed consent from all patients enrolled in the study.
- 9.Panichi V, Rocchetti MT, Scatena A et al (2017) Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study. J Nephrol 30(4):583–591CrossRefGoogle Scholar
- 11.Mion M, Kerr PG, Argiles A et al (1992) Haemodiafiltration in high-cardiovascular-risk patients. Nephrol Dial Transpl 7(5):453–454Google Scholar
- 16.In: Narins RGE (ed) (1994) Maxwell and Kleeman’s clinical disorders of fluid and electrolyte metabolism. McGraw Hill, New York, pp 583–615Google Scholar
- 25.Maggiore Q, Pizzarelli F, Zoccali C et al (1981) Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transpl Assoc 18:597–602Google Scholar
- 26.Maggiore Q, Pizzarelli F, Sisca S et al (1982) Blood temperature and vascular stability during hemodialysis and hemofiltration. Trans Am Soc Artif Intern Organs 28:523–527Google Scholar
- 28.Mahida BH, Dumler F, Zasuwa G et al (1983) Effect of cooled dialysate on serum catecholamines and blood pressure stability. Trans Am Soc Artif Intern Organs 29:384–389Google Scholar
- 31.Righetti M (2012) Internal hemodiafiltration. G Ital Nefrol 29(Suppl 55):S57–S61Google Scholar